Should I buy or sell Organigram stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Organigram in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" OGI shares. View OGI analyst ratings or view top-rated stocks .

What is Organigram's stock price target for 2024?

3 Wall Street analysts have issued twelve-month price targets for Organigram's stock. Their OGI share price targets range from C$2.70 to C$5.25. On average, they expect the company's share price to reach C$3.85 in the next twelve months. This suggests a possible upside of 47.5% from the stock's current price. View analysts price targets for OGI or view top-rated stocks among Wall Street analysts .

How have OGI shares performed in 2024?

Organigram's stock was trading at C$1.72 at the beginning of the year. Since then, OGI shares have increased by 51.7% and is now trading at C$2.61. View the best growth stocks for 2024 here .

When is Organigram's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 23rd 2024. View our OGI earnings forecast .

How were Organigram's earnings last quarter?

Organigram Holdings Inc. (TSE:OGI) announced its quarterly earnings results on Tuesday, February, 13th. The company reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of ($0.13) by $0.06. The company had revenue of $36.46 million for the quarter, compared to analyst estimates of $38.13 million. Organigram had a negative net margin of 153.80% and a negative trailing twelve-month return on equity of 54.53%.

What other stocks do shareholders of Organigram own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Organigram investors own include Aurora Cannabis (ACB) , Innovative Industrial Properties (IIPR) , Canopy Growth (WEED) , Aphria (APHA) , Aurora Cannabis (ACBFF) , Green Organic Dutchman (TGOD) , Charlotte's Web (CWBHF) and CannTrust (CTST) .

How do I buy shares of Organigram?

Shares of OGI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

TSE:OGI

Organigram (OGI) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free OGI Stock Alerts

C$2.61

+0.02 (+0.77%)

(As of 04/19/2024 ET)

Compare

Today's Range: C$2.56
▼
C$2.69
50-Day Range: C$2.50
▼
C$3.67
52-Week Range: C$1.35
▼
C$3.95

Volume: 465,095 shs
Average Volume: 403,491 shs
Market Capitalization: C$245.60 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: C$3.85

Stock Analysis Analyst Forecasts Chart Competitors Earnings Headlines

Get Organigram alerts:

Organigram MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.67 Rating Score
Upside/Downside: 47.5% Upside
C$3.85 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Selling Shares
C$62,965 Sold Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.43 out of 5 stars

3.3

Analyst's Opinion

Consensus Rating
Organigram has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
Organigram has only been the subject of 3 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for OGI.

0.0

Dividend Strength

Dividend Yield
Organigram does not currently pay a dividend.
Dividend Growth
Organigram does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for OGI.

1.1

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 1 news article for Organigram this week, compared to 1 article on an average week.
Search Interest
15 people have searched for OGI on MarketBeat in the last 30 days. This is an increase of 88% compared to the previous 30 days.
MarketBeat Follows
2 people have added Organigram to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Organigram insiders have sold more of their company's stock than they have bought. Specifically, they have bought C$0.00 in company stock and sold C$62,965.00 in company stock.
Percentage Held by Insiders
34.74% of the stock of Organigram is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 11.20% of the stock of Organigram is held by institutions.

1.9

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Organigram is -1.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Organigram is -1.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
Organigram has a PEG Ratio of 0.42. PEG Ratios below 1 indicate that a company could be undervalued.
Price to Book Value per Share Ratio
Organigram has a P/B Ratio of 0.82. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Organigram Stock (TSE:OGI)

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

OGI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

OGI Stock News Headlines

April 18, 2024 | finance.yahoo.com

Organigram Holdings Inc. (OGI)

April 8, 2024 | finance.yahoo.com

Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

March 29, 2024 | benzinga.com

Canadian Cannabis Giant Sets Stage For Growth With $18.5M Public Offering

March 28, 2024 | cnn.com

OrganiGram Holdings Inc

March 28, 2024 | msn.com

Organigram Holdings (TSE:OGI) Plunges amid Plans to Enter U.S. Market

March 27, 2024 | theglobeandmail.com

OrganiGram Holdings: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (OGI)

March 27, 2024 | msn.com

Organigram slips after announcing C$25M stock offering

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

March 26, 2024 | msn.com

Organigram spikes after $2M investment in U.S.-based cannabinoid player

March 22, 2024 | finance.yahoo.com

Organigram Receives Health Canada’s Final Redetermination on Jolts

March 16, 2024 | finance.yahoo.com

OGI Apr 2024 1.500 put

March 11, 2024 | theglobeandmail.com

Strategic Investing with Eternity INC: A Guide to Building a Resilient Portfolio

February 28, 2024 | finance.yahoo.com

Organigram Applauds the Standing Committee on Finance’s Recommendation on Excise Duty

February 24, 2024 | fool.ca

The Best Cannabis Stock to Buy Right Now

February 16, 2024 | finance.yahoo.com

OGI Mar 2024 2.000 call

February 15, 2024 | seekingalpha.com

Organigram Holdings Inc. (OGI) Q1 2024 Earnings Call Transcript

February 14, 2024 | finance.yahoo.com

OrganiGram Holdings Inc. (NASDAQ:OGI) Q1 2024 Earnings Call Transcript

February 13, 2024 | markets.businessinsider.com

Buy Rating Affirmed for OrganiGram Holdings Amid Strong Profit Margins and Strategic Market Positioning

February 10, 2024 | ca.finance.yahoo.com

OGI Sep 2024 2.000 put

February 10, 2024 | ca.finance.yahoo.com

OGI Sep 2024 5.000 call

January 31, 2024 | finance.yahoo.com

Organigram Completes First Shipment to Germany, Extending its International Reach

January 24, 2024 | finance.yahoo.com

Organigram Announces the First Tranche Closing from BAT Investment

January 22, 2024 | theglobeandmail.com

OrganiGram Holdings: Top 10 Undervalued Drug Manufacturers Industry Stocks (OGI)

January 2, 2024 | seekingalpha.com

Why Organigram Is My Favorite Cannabis Stock

December 29, 2023 | finance.yahoo.com

Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting

December 25, 2023 | markets.businessinsider.com

Jefferies Reaffirms Their Buy Rating on OrganiGram Holdings (OGI)

See More Headlines

Receive OGI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/13/2024
Today: 4/19/2024
Next Earnings (Estimated): 4/23/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: Cannabis
Current Symbol: TSE:OGI
CUSIP: N/A
CIK: N/A
Web: www.organigram.ca
Phone: 844-644-4726
Fax: N/A
Employees: 984
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: C$3.85
High Stock Price Target: C$5.25
Low Stock Price Target: C$2.70
Potential Upside/Downside: +47.5%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.67
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): C($2.51)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 28.32
P/E Growth: 0.42
Net Income: C$-229,480,000.00
Net Margins: -153.80%
Pretax Margin: N/A
Return on Equity: -54.53%
Return on Assets: -5.56%

Debt

Debt-to-Equity Ratio: 1.75
Current Ratio: 6.95
Quick Ratio: 2.62

Sales & Book Value

Annual Sales: C$149.21 million
Price / Sales: 1.65
Cash Flow: C$0.68 per share
Price / Cash Flow: 3.85
Book Value: C$3.18 per share
Price / Book: 0.82

Miscellaneous

Outstanding Shares: 94,100,000
Free Float: N/A
Market Cap: C$245.60 million
Optionable: Not Optionable
Beta: 1.11

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Ms. Beena G. Goldenberg (Age 60)
CEO & Director
Comp: $485.33k
Ms. Helen Martin (Age 46)
Chief Legal Officer & Corporate Secretary
Comp: $307.95k
Mr. Timothy Emberg
Chief Commercial Officer
Mr. Paolo De Luca C.A. (Age 51)
C.F.A, Chief Strategy Officer
Comp: $306.7k
Mr. Greg Guyatt C.A.
CPA, Chief Financial Officer
Ms. Nathalie Batten
Senior Vice President of Operations
Mr. Geoff Riggs
Chief Information Officer
Max Schwartz
Director of Investor Relations
Ms. Megan Amber McCrae
Senior Vice President of Marketing & Communications
Ms. Katrina May McFadden
Chief People Officer

Key Competitors

View All Competitors

Insiders

Donald Geoffrey Machum
Sold 23,000 shares
Total: C$62,964.80 ($2.74/share)

OGI Stock Analysis - Frequently Asked Questions

Should I buy or sell Organigram stock right now?: 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Organigram in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" OGI shares.
View OGI analyst ratings or view top-rated stocks.
What is Organigram's stock price target for 2024?: 3 Wall Street analysts have issued twelve-month price targets for Organigram's stock. Their OGI share price targets range from C$2.70 to C$5.25. On average, they expect the company's share price to reach C$3.85 in the next twelve months. This suggests a possible upside of 47.5% from the stock's current price.
View analysts price targets for OGI or view top-rated stocks among Wall Street analysts.
How have OGI shares performed in 2024?: Organigram's stock was trading at C$1.72 at the beginning of the year. Since then, OGI shares have increased by 51.7% and is now trading at C$2.61.
View the best growth stocks for 2024 here.
When is Organigram's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 23rd 2024.
View our OGI earnings forecast.

How were Organigram's earnings last quarter?: Organigram Holdings Inc. (TSE:OGI) announced its quarterly earnings results on Tuesday, February, 13th. The company reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of ($0.13) by $0.06. The company had revenue of $36.46 million for the quarter, compared to analyst estimates of $38.13 million. Organigram had a negative net margin of 153.80% and a negative trailing twelve-month return on equity of 54.53%.
What other stocks do shareholders of Organigram own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Organigram investors own include Aurora Cannabis (ACB), Innovative Industrial Properties (IIPR), Canopy Growth (WEED), Aphria (APHA), Aurora Cannabis (ACBFF), Green Organic Dutchman (TGOD), Charlotte's Web (CWBHF) and CannTrust (CTST).
How do I buy shares of Organigram?: Shares of OGI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:OGI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Organigram (OGI) Stock Price, News & Analysis

Organigram MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Organigram Stock (TSE:OGI)

OGI Stock Price History

OGI Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

OGI Stock Analysis - Frequently Asked Questions

Overall MarketRank^™